Mass versus personalized medicine against COVID-19 in the “system sciences” era

Laura Teodori; Barbara Osimani; Ciro Isidoro; Seeram Ramakrishna

doi:10.1002/cyto.a.24662

Mass versus personalized medicine against COVID-19 in the “system sciences” era

Laura Teodori
, Barbara Osimani
, Ciro Isidoro
, Seeram Ramakrishna

Department of Health Sciences

Research output: Contribution to journal › Comment/debate

Abstract

The importance of personalized/precision medicine for targeted therapies and improved outcomes both in terms of efficacy and safety in health care is by now grounded. We here discuss the current landscape of personalized medicine approaches against SARS-CoV-2. A schematic of the approach is illustrated in the figure in the text.

Original language	English
Pages (from-to)	995-999
Number of pages	5
Journal	Cytometry. Part A : the journal of the International Society for Analytical Cytology
Volume	101
Issue number	12
DOIs	https://doi.org/10.1002/cyto.a.24662
Publication status	Published - Dec 2022

Keywords

SARS-CoV-2
multi-omics landscape
patient heterogeneity
precision medicine
virus heterogeneity

Access to Document

10.1002/cyto.a.24662

Cite this

@article{6e13211f259d46ee8a428f0f5d24236c,

title = "Mass versus personalized medicine against COVID-19 in the {\textquotedblleft}system sciences{\textquotedblright} era",

abstract = "The importance of personalized/precision medicine for targeted therapies and improved outcomes both in terms of efficacy and safety in health care is by now grounded. We here discuss the current landscape of personalized medicine approaches against SARS-CoV-2. A schematic of the approach is illustrated in the figure in the text.",

keywords = "SARS-CoV-2, multi-omics landscape, patient heterogeneity, precision medicine, virus heterogeneity",

author = "Laura Teodori and Barbara Osimani and Ciro Isidoro and Seeram Ramakrishna",

note = "Publisher Copyright: {\textcopyright} 2022 International Society for Advancement of Cytometry.",

year = "2022",

month = dec,

doi = "10.1002/cyto.a.24662",

language = "English",

volume = "101",

pages = "995--999",

journal = "Cytometry. Part A : the journal of the International Society for Analytical Cytology",

issn = "1552-4922",

publisher = "John Wiley and Sons Inc.",

number = "12",

}

TY - JOUR

T1 - Mass versus personalized medicine against COVID-19 in the “system sciences” era

AU - Teodori, Laura

AU - Osimani, Barbara

AU - Isidoro, Ciro

AU - Ramakrishna, Seeram

PY - 2022/12

Y1 - 2022/12

N2 - The importance of personalized/precision medicine for targeted therapies and improved outcomes both in terms of efficacy and safety in health care is by now grounded. We here discuss the current landscape of personalized medicine approaches against SARS-CoV-2. A schematic of the approach is illustrated in the figure in the text.

AB - The importance of personalized/precision medicine for targeted therapies and improved outcomes both in terms of efficacy and safety in health care is by now grounded. We here discuss the current landscape of personalized medicine approaches against SARS-CoV-2. A schematic of the approach is illustrated in the figure in the text.

KW - SARS-CoV-2

KW - multi-omics landscape

KW - patient heterogeneity

KW - precision medicine

KW - virus heterogeneity

UR - https://www.scopus.com/pages/publications/85132121183

U2 - 10.1002/cyto.a.24662

DO - 10.1002/cyto.a.24662

M3 - Comment/debate

SN - 1552-4922

VL - 101

SP - 995

EP - 999

JO - Cytometry. Part A : the journal of the International Society for Analytical Cytology

JF - Cytometry. Part A : the journal of the International Society for Analytical Cytology

IS - 12

ER -

Mass versus personalized medicine against COVID-19 in the “system sciences” era

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this